title: Synergistic effects of verapamil and anti-mdr1 ribozyme on reversion of multidrug resistance in the P-glycoprotein-positive K562 cell line.
authors.forename: Y
authors.initials: Y
authors.lastname: Gong
authors.forename: W
authors.initials: W
authors.lastname: Han
authors.forename: J
authors.initials: J
authors.lastname: Liu
authors.forename: F
authors.initials: F
authors.lastname: Chen
authors.forename: J
authors.initials: J
authors.lastname: Han
authors.forename: Y
authors.initials: Y
authors.lastname: Jin
authors.forename: R O
authors.initials: RO
authors.lastname: Yong
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors*; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D004357:Drug Synergism; D006801:Humans; D020014:K562 Cells; D016337:RNA, Catalytic / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology*
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D016337:RNA, Catalytic; D014700:Verapamil